e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Immune aspects of asthma and other airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness
Utako Fujii (Okahama, Japan), Utako Fujii, Arihiko Kanehiro, Hiroki Kakuta, Akihiko Taniguchi, Daisuke Morichika, Genyo Ikeda, Genyo Ikeda, Hikari Nakayama, Koichi Waseda, Etsuko Murakami, Nobuaki Miyahara, Mikio Kataoka, Mitsune Tanimoto
Source:
International Congress 2015 – Immune aspects of asthma and other airway diseases
Session:
Immune aspects of asthma and other airway diseases
Session type:
Thematic Poster Session
Number:
4007
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Utako Fujii (Okahama, Japan), Utako Fujii, Arihiko Kanehiro, Hiroki Kakuta, Akihiko Taniguchi, Daisuke Morichika, Genyo Ikeda, Genyo Ikeda, Hikari Nakayama, Koichi Waseda, Etsuko Murakami, Nobuaki Miyahara, Mikio Kataoka, Mitsune Tanimoto. Effect of retinoid X receptor partial agonist on airway inflammation and hyperresponsiveness. Eur Respir J 2015; 46: Suppl. 59, 4007
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Alpha-7 nicotinic receptor stimulation reduces airway inflammation in a murine model of asthma
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
The muscarinic M
3
receptor regulates allergen-induced airway remodeling in mice
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
A novel inhaled PI3Kδ inhibitor, LAS194223 reduces allergen-induced airway inflammation in rat
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Andrographolide restores steroid sensitivity to block LPS/IFN-γ-induced IL-27 and airway hyperresponsiveness in mice
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Influence of beta2-adrenergic receptor polymorphism on methacholine hyperresponsiveness in asthmatic patients
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Aerobic training reverses the inhibition in the expression of glucocorticoid receptors and decreases the Th2 allergic inflammation in asthma model
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Nicotine impairs inflammation-induced airway relaxation in a in vitro murine model of asthma
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
LATE-BREAKING ABSTRACT: A novel role for CCR3 in promoting airways hyperreactivity; Role for CCR3-muscarinic M3 receptor heterodimers
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Bcl-2 antagonist ABT-737 attenuates corticosteroid-insensitive neutrophilic airway inflammation
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Low level laser in monotherapy or in combination with leukotriene receptor antagonists in the treatment of allergic lung inflammation
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Combined loss of M2 and M3 muscarinic acetylcholine receptor (mAChR) function in mutant mice increases serotonin airway responsiveness (AR)
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
IL-13 in a mouse model of chemical-induced airway hyperresponsiveness
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Lipopolysacharide modulates glucocorticoid receptor function in nasal mucosa and polyp fibroblasts
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013
Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept